IVD Antibodies for Cancer

Utilizing decades of antibody development expertise, Rockland has created a portfolio of specific antibodies for detection of targets associated with various types of cancer. Many antibodies have been developed in cooperation with renowned institutions like the National Cancer Institute, The Wistar Institute, Emory University, and others. By combining basic and applied research principles and working closely with life science researchers, Rockland continually strives to develop highly-characterized antibodies that recognize relevant cancer targets.